ETSA winner Theranautilus heads to human trials; JSW One’s IPO plans
Happy Friday! Theranautilus is set to begin human trials of its nanorobot-based dental tech soon. This and more in today’s ETtech Morning Dispatch.
Theranautilus, a Bengaluru-based deeptech startup, is set to commence human trials of its nanorobot-based dental technology in November-December. The trials will begin with 30 patients, followed by a 300-patient multicentric trial, with the goal of commercialisation within two years for oral health and four to five years for oncology applications.
Written by urgent.news from Economic Times Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
